시장보고서

상품코드

1571569

구제역 백신 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 백신별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

구제역 백신 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 구제역 백신 시장 규모는 2024년부터 2030년까지 8.2%의 CAGR을 기록하며 2030년까지 38억 8,000만 달러에 달할 것으로 예상됩니다.

FMD 발생률의 증가와 축산물 국제 거래에 미치는 사회경제적 영향은 FMD 백신에 대한 수요를 증가시키고 있습니다. 또한 백신의 유효기간이 짧기 때문에 반복적으로 구매하는 경향이 있습니다.

이 시장은 경쟁이 치열하고 다양한 정부 기관이 백신 대량 구매에 개입하고 있습니다. 지난 수십 년 동안 전 세계 가축 사육두수는 역동적으로 증가하고 있습니다. 개발도상국에서는 축산물에 대한 수요가 증가하고 있으며, 이에 따라 가축의 건강에 대한 관심이 높아지고 있습니다. 축산물에 대한 수요 증가는 세계 축산업에 혁명을 일으켰습니다. 또한, 라이프스타일의 변화로 인한 식습관 변화와 인구 증가 등의 요인이 축산물 수요를 증가시킬 것으로 예상됩니다.

높은 효능으로 인해 유성 백신의 채택이 증가함에 따라 재래식 백신의 최대 점유율을 차지할 것으로 예상됩니다. 사용 가능한 기존 백신은 임상 질환 예방에 효과적이지만 보호 기간이 짧습니다. 따라서 예방 조치로 빈번한 백신 접종이 필요합니다.

구제역 백신 시장 보고서 하이라이트

불활성화(사멸) 백신 부문이 시장을 장악하고 있으며, 2023년 시장 점유율은 53.0%를 기록했습니다.
2023년 시장 점유율은 소가 53.5%로 시장을 장악했으며, 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
돼지 부문은 예측 기간 동안 상당한 CAGR로 성장할 것으로 예상됩니다. 이는 돼지고기가 양질의 단백질 공급원이자 전 세계 많은 개발도상국에서 수입원이 되고 있기 때문에 돼지고기에 대한 수요가 증가하고 있기 때문입니다.
아시아태평양 구제역 백신 시장은 2023년 48.2%의 매출 점유율로 우위를 차지했습니다.

구제역 백신 시장 점유율, 지역별, 2023년 및 2030년
유럽
- 러시아
- 프랑스
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 인도네시아
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
- 이집트
- 터키

제8장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Merck &Co., Inc.
- Biogenesis Bago
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Limited
- Bayer AG
- Hester Biosciences Limited
- Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
- Brilliant Bio Pharma Limited
- Biovet Private Ltd

ksm 24.10.31

Foot And Mouth Disease Vaccine Market Growth & Trends:

The global foot and mouth disease vaccine market size is expected to reach USD 3.88 billion by 2030, registering a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for a lower time period propels the repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as a change in food preferences owing to changing lifestyles coupled with a growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Foot And Mouth Disease Vaccine Market Report Highlights:

The inactivated (killed) vaccine segment dominated the market and accounted for a market share of 53.0% in 2023.
Cattle dominated the market with a market share of 53.5% in 2023 and is expected to grow at the fastest CAGR over the forecast period.
The swine segment is expected to grow at a significant CAGR over the forecast period. It is attributed to the rising demand for pork as it is a good source of protein and income source in many developing countries across the world.
Asia Pacific foot & mouth disease vaccine market dominated with a revenue share of 48.2% in 2023 owing to the growing livestock population and high prevalence of FMD in this region.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Foot & Mouth Disease Vaccine Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Foot & Mouth Disease Vaccine Market: Animal Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
4.3. Cattle
- 4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sheep and Goat
- 4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Swine
- 4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Foot & Mouth Disease Vaccine Market: Vaccine Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
5.3. Modified/ Attenuated Live
- 5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated (Killed)
- 5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
- 5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Foot & Mouth Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Veterinary Hospitals & Clinics
- 6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Government Institutions
- 6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Foot & Mouth Disease Vaccine Market: Regional Estimates & Trend Analysis

7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Europe
- 7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. Russia
  - 7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. France
  - 7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
- 7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Japan
  - 7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. China
  - 7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. India
  - 7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. South Korea
  - 7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Indonesia
  - 7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. South Korea
  - 7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Thailand
  - 7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
- 7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Brazil
  - 7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Argentina
  - 7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East and Africa
- 7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. South Africa
  - 7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Saudi Arabia
  - 7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. UAE
  - 7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Kuwait
  - 7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Egypt
  - 7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Turkey
  - 7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Merck & Co., Inc.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Biogenesis Bago
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Zoetis Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Boehringer Ingelheim International GmbH
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Indian Immunologicals Limited
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Bayer AG
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Hester Biosciences Limited
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Brilliant Bio Pharma Limited
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Biovet Private Ltd
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

구제역 백신 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 백신별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

구제역 백신 시장 성장과 동향:

구제역 백신 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 구제역 백신 시장 변수, 동향, 범위

제4장 구제역 백신 시장 : 동물 추정·동향 분석

제5장 구제역 백신 시장 : 백신 추정·동향 분석

제6장 구제역 백신 시장 : 유통 채널 추정·동향 분석

제7장 구제역 백신 시장 : 지역 추정·동향 분석